Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  ConvaTec Group    CTEC   GB00BD3VFW73

CONVATEC GROUP (CTEC)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
02/19/2018 02/20/2018 02/21/2018 02/22/2018 02/23/2018 Date
212.3(c) 214.8(c) 211(c) 211.6(c) 211.4(c) Last
3 234 000 5 258 177 16 195 612 4 889 590 8 507 129 Volume
-1.39% +1.18% -1.77% +0.28% -0.09% Change
More quotes
Financials ($)
Sales 2018 1 869 M
EBIT 2018 405 M
Net income 2018 219 M
Debt 2018 1 295 M
Yield 2018 2,30%
Sales 2019 1 950 M
EBIT 2019 450 M
Net income 2019 264 M
Debt 2019 1 045 M
Yield 2019 2,57%
P/E ratio 2018 24,99
P/E ratio 2019 21,03
EV / Sales2018 3,78x
EV / Sales2019 3,49x
Capitalization 5 763 M
More Financials
Company
ConvaTec Group Plc is a holding company engages in medical business.Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy... 
More about the company
Surperformance© ratings of ConvaTec Group
Trading Rating : Investor Rating :
More Ratings
Latest news on CONVATEC GROUP
02/21MEDTRONIC : Introduces MiniMed Mio Advance Infusion Set for People with Diabetes
AQ
02/20Merlin shares boosted by valueact taking stake
AQ
02/16CONVATEC : growth excels but issues to seep into 2018
AQ
02/15Cyclicals, South Africa-exposed stocks help steady FTSE 100
RE
02/15COLOPLAST A/S : ConvaTec beats low full-year expectations, shares rise
RE
2017CONVATEC : Organisation Appointments 04 December 2017
PU
2017CONVATEC : Organisation Appointments
PU
2017A TASTE FOR SUCCESS Online delivery startup Just Eat promoted to the FTSE 100
AQ
2017Just Eat to join top table of British business
RE
2017CONVATEC : stock recovers after UBS upgrade
AQ
More news
Sector news : Specialty & Advanced Pharmaceuticals
02/23PUMA BIOTECHNOLOGY : EU panel recommends against nod for Puma Biotech's breast c..
RE
02/23SANOFI : Says U.S. Waiting Period for Bioverativ Has Expired
DJ
02/23SHIRE : FDA to Conduct Priority Review of Shire Genetic-Disorder Drug
DJ
02/23NOVARTIS : Greek Parliament Approves Bribery and Price Fix Inquiry on Novartis -..
DJ
02/22NOVARTIS : Greek Parliament Investigates Politicians in Novartis Bribery Probe
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Latest Tweets
02/23ConvaTec Group's overweight rating reiterated at Morgan Stanley. GBX 249 PT. .. 
02/15ConvaTec rallies after sales defy downbeat City forecasts  
02/15Graeme Davies: News & Tips: South32, ConvaTec, Standard Life Aberdeen &a.. 
02/15My latest write-up @ShareProphets "#ConvaTec - let's talk #colostomy bags » V.. 
02/15Just posted: ConvaTec - let's talk colostomy bags  
More tweets
Qtime:40
News from SeekingAlpha
2017Convatec (CNVVY) Q3 Trading Update - Slideshow 
2017SNIPPET ROUNDUP : Novartis Meets CAR-T Filing Deadline, Numab Snares Ono 
Chart CONVATEC GROUP
Duration : Period :
ConvaTec Group Technical Analysis Chart | CTEC | GB00BD3VFW73 | 4-Traders
Technical analysis trends CONVATEC GROUP
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 3,05 $
Spread / Average Target 3,9%
EPS Revisions
Managers
NameTitle
Paul Moraviec Chief Executive Officer & Director
Christopher Charles Gent Non-Executive Chairman
Frank M. Schulkes Chief Financial Officer
Robert Steele EVP-Quality, Clinical & Regulatory Affairs
Steven John Holliday Deputy Chairman
Sector and Competitors
1st jan.Capitalization (M$)
CONVATEC GROUP2.87%5 763
ABBVIE21.92%188 235
MERCK KGAA-8.21%13 090
KYOWA HAKKO KIRIN CO LTD2.75%12 169
JAZZ PHARMACEUTICALS PLC7.26%8 716
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD16.12%6 887